SonoFirst
Opening the brain blood barrier to treat brain tumours
A clinical trial for a revolutionairy device to deliver cancer treatment
Presentation of the trialNews
See all the newsOpening of the Paris site, Pitié-Salpêtrière, on 21 June 2021
Randomised, open-label, multi-site phase II clinical trial in newly diagnosed glioblastoma treated with surgery, concomitant temoradiation and adjuvant temozolomide +/- […]
Read moreNews
See all the newsParticipation in Brain Week 2021
Organised every year in March since 1999, Brain Week is an international event, held simultaneously in a hundred countries and […]
Read moreNews
See all the newsParticipation in Brain Innovation Days
A new technology called SonoCloud uses low ultrasonic energy to stimulate microbubbles that stretch capillary walls and create a temporary […]
Read moreNews
See all the newsUltrasound to permeate brain vessels
SonoFIRST Prof. Alexandre Carpentier and his teams have developed an ultrasound technology (SonoCLOUD) to temporarily permeabilise the hematoencephalic barrier to […]
Read moreNews
See all the newsLaunch of the SonoFIRST project
Glioblastoma (GBM) is the most common and aggressive form of primary brain cancer. The prognosis is currently very poor, with […]
Read moreNews
See all the newsOpening the brain blood barrier to treat brain tumours
A clinical trial for a revolutionairy device to deliver cancer treatment Glioblastoma, the most common form of malignant primary brain […]
Read moreKey numbers
Start date of the study
Opening of the Paris site, Pitié-Salpêtrière, on 21 June 2021.
Read morePartners
